Steven Post
Concepts (444)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Scavenger Receptors, Class A | 13 | 2017 | 39 | 2.530 |
Why?
| Herpesvirus 8, Human | 12 | 2025 | 95 | 1.930 |
Why?
| Macrophages | 7 | 2019 | 361 | 1.560 |
Why?
| Sarcoma, Kaposi | 10 | 2025 | 75 | 1.350 |
Why?
| Virus Activation | 8 | 2025 | 35 | 1.020 |
Why?
| Signal Transduction | 22 | 2022 | 1608 | 0.830 |
Why?
| Macrophage Colony-Stimulating Factor | 3 | 2011 | 10 | 0.800 |
Why?
| Tumor Microenvironment | 2 | 2024 | 221 | 0.790 |
Why?
| Cell Adhesion | 8 | 2016 | 155 | 0.790 |
Why?
| Phospholipases A2 | 3 | 2014 | 15 | 0.780 |
Why?
| Phosphatidylinositol 3-Kinases | 4 | 2014 | 139 | 0.760 |
Why?
| Vulvar Neoplasms | 3 | 2016 | 58 | 0.720 |
Why?
| Monocytes | 2 | 2019 | 131 | 0.670 |
Why?
| Plasma Cells | 2 | 2018 | 221 | 0.670 |
Why?
| Animals | 43 | 2023 | 13100 | 0.670 |
Why?
| Hodgkin Disease | 1 | 2019 | 44 | 0.660 |
Why?
| Antigens, CD | 2 | 2019 | 215 | 0.650 |
Why?
| Peripheral Nerves | 2 | 2015 | 48 | 0.620 |
Why?
| Coinfection | 4 | 2025 | 42 | 0.610 |
Why?
| Color | 1 | 2018 | 22 | 0.610 |
Why?
| Automation | 1 | 2018 | 17 | 0.610 |
Why?
| Carcinoma, Squamous Cell | 3 | 2016 | 330 | 0.610 |
Why?
| Cyclic AMP | 9 | 2000 | 92 | 0.600 |
Why?
| Immunophenotyping | 1 | 2018 | 109 | 0.600 |
Why?
| Blood Coagulation Tests | 1 | 2017 | 19 | 0.590 |
Why?
| Optics and Photonics | 1 | 2017 | 11 | 0.590 |
Why?
| Mice | 26 | 2023 | 5658 | 0.590 |
Why?
| Diagnostic Tests, Routine | 1 | 2017 | 28 | 0.580 |
Why?
| Macrophages, Peritoneal | 6 | 2009 | 31 | 0.580 |
Why?
| Immunoglobulins | 1 | 2017 | 79 | 0.570 |
Why?
| Membrane Proteins | 5 | 2023 | 347 | 0.560 |
Why?
| Lipoproteins, LDL | 6 | 2011 | 169 | 0.550 |
Why?
| Receptors, Purinergic P2 | 5 | 2001 | 39 | 0.550 |
Why?
| Cytoplasm | 2 | 2009 | 93 | 0.540 |
Why?
| Breast Neoplasms | 2 | 2024 | 1184 | 0.540 |
Why?
| Bone Marrow | 1 | 2018 | 351 | 0.530 |
Why?
| Cell Line | 12 | 2021 | 1010 | 0.520 |
Why?
| Gelatinases | 1 | 2016 | 32 | 0.520 |
Why?
| Serine Endopeptidases | 1 | 2016 | 51 | 0.510 |
Why?
| Collagen Type I | 1 | 2016 | 83 | 0.500 |
Why?
| Flow Cytometry | 1 | 2018 | 470 | 0.500 |
Why?
| Interleukin-6 | 1 | 2016 | 265 | 0.490 |
Why?
| Humans | 47 | 2025 | 49929 | 0.490 |
Why?
| Sepsis | 2 | 2014 | 220 | 0.490 |
Why?
| Klebsiella Infections | 1 | 2014 | 12 | 0.480 |
Why?
| Klebsiella pneumoniae | 1 | 2014 | 20 | 0.480 |
Why?
| Pneumonia, Bacterial | 1 | 2014 | 27 | 0.480 |
Why?
| Membrane Microdomains | 1 | 2014 | 12 | 0.480 |
Why?
| Thrombocytopenia | 1 | 2014 | 79 | 0.450 |
Why?
| Hemorrhage | 1 | 2014 | 194 | 0.430 |
Why?
| Myocytes, Cardiac | 1 | 2013 | 122 | 0.410 |
Why?
| Neoplasm Recurrence, Local | 2 | 2015 | 626 | 0.400 |
Why?
| Heterotrimeric GTP-Binding Proteins | 2 | 2002 | 7 | 0.400 |
Why?
| Cell Membrane | 4 | 2009 | 249 | 0.390 |
Why?
| Receptors, Scavenger | 6 | 2017 | 29 | 0.380 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 96 | 0.370 |
Why?
| Adenosine Triphosphate | 4 | 2001 | 231 | 0.350 |
Why?
| Mouth | 2 | 2020 | 31 | 0.340 |
Why?
| Receptors, Immunologic | 4 | 2017 | 37 | 0.340 |
Why?
| Transcription Factors | 1 | 2013 | 565 | 0.340 |
Why?
| Cells, Cultured | 9 | 2020 | 1587 | 0.330 |
Why?
| Receptors, Adrenergic, beta | 4 | 1999 | 42 | 0.330 |
Why?
| Antiviral Agents | 2 | 2021 | 168 | 0.320 |
Why?
| Epithelial Cells | 2 | 2001 | 209 | 0.300 |
Why?
| GTP-Binding Proteins | 8 | 2000 | 93 | 0.300 |
Why?
| Enzyme Activation | 5 | 2014 | 272 | 0.300 |
Why?
| rac GTP-Binding Proteins | 1 | 2007 | 5 | 0.300 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2007 | 13 | 0.300 |
Why?
| Arachidonate 15-Lipoxygenase | 1 | 2007 | 13 | 0.300 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2007 | 11 | 0.300 |
Why?
| HIV Infections | 3 | 2020 | 355 | 0.290 |
Why?
| Receptors, Transferrin | 2 | 2004 | 16 | 0.290 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 178 | 0.280 |
Why?
| Immunohistochemistry | 4 | 2021 | 972 | 0.270 |
Why?
| src-Family Kinases | 1 | 2006 | 51 | 0.270 |
Why?
| Partial Thromboplastin Time | 2 | 2017 | 12 | 0.260 |
Why?
| Prothrombin Time | 2 | 2017 | 18 | 0.260 |
Why?
| Stromal Cells | 2 | 2016 | 72 | 0.260 |
Why?
| Female | 15 | 2024 | 26576 | 0.250 |
Why?
| Protein Isoforms | 3 | 2019 | 118 | 0.250 |
Why?
| Pertussis Toxin | 2 | 2002 | 11 | 0.230 |
Why?
| Histamine | 2 | 2023 | 25 | 0.230 |
Why?
| Biopsy | 2 | 2016 | 591 | 0.220 |
Why?
| Lymph Nodes | 2 | 2016 | 257 | 0.220 |
Why?
| Oncogenic Viruses | 2 | 2021 | 15 | 0.220 |
Why?
| Retrospective Studies | 5 | 2019 | 6124 | 0.220 |
Why?
| Echinomycin | 1 | 2023 | 6 | 0.220 |
Why?
| Receptors, Gastrointestinal Hormone | 2 | 1993 | 4 | 0.220 |
Why?
| Ligands | 5 | 2017 | 203 | 0.210 |
Why?
| Glucagon | 2 | 1993 | 22 | 0.210 |
Why?
| Prostatitis | 1 | 2023 | 10 | 0.210 |
Why?
| Focal Adhesions | 1 | 2002 | 14 | 0.210 |
Why?
| Mice, Knockout | 5 | 2014 | 835 | 0.210 |
Why?
| Proteoglycans | 1 | 2023 | 81 | 0.210 |
Why?
| Oncolytic Virotherapy | 1 | 2022 | 18 | 0.210 |
Why?
| Mice, Inbred C57BL | 6 | 2016 | 1777 | 0.210 |
Why?
| Herpesviridae | 1 | 2022 | 17 | 0.200 |
Why?
| Protein Binding | 4 | 2014 | 656 | 0.200 |
Why?
| Lung Neoplasms | 2 | 2021 | 602 | 0.200 |
Why?
| Dogs | 8 | 2001 | 185 | 0.200 |
Why?
| von Willebrand Factor | 2 | 2019 | 43 | 0.200 |
Why?
| Epstein-Barr Virus Infections | 1 | 2022 | 29 | 0.200 |
Why?
| MicroRNAs | 2 | 2023 | 347 | 0.190 |
Why?
| Neoplasms | 2 | 2023 | 1234 | 0.190 |
Why?
| Protein Transport | 3 | 2014 | 183 | 0.190 |
Why?
| Students, Medical | 1 | 2023 | 159 | 0.190 |
Why?
| Virulence Factors, Bordetella | 2 | 2000 | 8 | 0.190 |
Why?
| Eukaryotic Initiation Factor-4G | 1 | 2021 | 5 | 0.190 |
Why?
| Lipoproteins, VLDL | 1 | 2000 | 9 | 0.180 |
Why?
| Sphingolipids | 1 | 2020 | 15 | 0.180 |
Why?
| Ceramides | 1 | 2020 | 31 | 0.180 |
Why?
| Male | 14 | 2023 | 25454 | 0.180 |
Why?
| Cell Line, Tumor | 6 | 2022 | 1388 | 0.180 |
Why?
| Virus Latency | 4 | 2023 | 51 | 0.180 |
Why?
| Neoplasm Invasiveness | 3 | 2016 | 268 | 0.180 |
Why?
| Middle Aged | 9 | 2020 | 12293 | 0.180 |
Why?
| Lymphoma, Primary Effusion | 1 | 2020 | 20 | 0.180 |
Why?
| Cell Survival | 3 | 2021 | 590 | 0.180 |
Why?
| Antigens, Bacterial | 1 | 2020 | 54 | 0.180 |
Why?
| Porphyromonas gingivalis | 1 | 2020 | 14 | 0.180 |
Why?
| Gene Regulatory Networks | 1 | 2021 | 107 | 0.170 |
Why?
| Mice, Transgenic | 3 | 2013 | 543 | 0.170 |
Why?
| Carcinoma, Hepatocellular | 1 | 2022 | 194 | 0.170 |
Why?
| Phenotype | 2 | 2019 | 728 | 0.170 |
Why?
| Cell Proliferation | 3 | 2021 | 986 | 0.170 |
Why?
| ABO Blood-Group System | 1 | 2019 | 15 | 0.170 |
Why?
| Blood Coagulation | 2 | 2017 | 58 | 0.170 |
Why?
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 4 | 0.170 |
Why?
| Drosophila Proteins | 1 | 2019 | 26 | 0.170 |
Why?
| Calcium Channels | 1 | 2019 | 47 | 0.170 |
Why?
| Recombinant Proteins | 3 | 2016 | 482 | 0.160 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2019 | 40 | 0.160 |
Why?
| Prostatic Neoplasms | 1 | 2023 | 391 | 0.160 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 155 | 0.160 |
Why?
| Receptors, LDL | 3 | 2004 | 67 | 0.160 |
Why?
| Liver Neoplasms | 1 | 2022 | 329 | 0.160 |
Why?
| Neoplasm Staging | 3 | 2016 | 749 | 0.160 |
Why?
| Pulmonary Embolism | 1 | 2019 | 98 | 0.150 |
Why?
| Mycobacterium tuberculosis | 1 | 2020 | 287 | 0.150 |
Why?
| Glycoproteins | 2 | 2012 | 115 | 0.150 |
Why?
| Host-Pathogen Interactions | 1 | 2019 | 136 | 0.150 |
Why?
| Herpesviridae Infections | 3 | 2025 | 53 | 0.150 |
Why?
| Myocardium | 3 | 1999 | 443 | 0.140 |
Why?
| Amino Acid Sequence | 4 | 2009 | 579 | 0.140 |
Why?
| Up-Regulation | 2 | 2011 | 446 | 0.140 |
Why?
| Odds Ratio | 2 | 2015 | 548 | 0.140 |
Why?
| Bacterial Proteins | 1 | 2020 | 372 | 0.140 |
Why?
| Molecular Sequence Data | 4 | 2009 | 799 | 0.140 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 824 | 0.140 |
Why?
| Cell Transformation, Neoplastic | 3 | 2023 | 181 | 0.140 |
Why?
| Heart | 1 | 1999 | 336 | 0.130 |
Why?
| Integrins | 1 | 2016 | 30 | 0.130 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 1996 | 16 | 0.130 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2016 | 49 | 0.130 |
Why?
| Receptors, Cell Surface | 3 | 2004 | 120 | 0.130 |
Why?
| Logistic Models | 2 | 2015 | 896 | 0.130 |
Why?
| Endopeptidases | 1 | 2016 | 66 | 0.130 |
Why?
| Anion Exchange Protein 1, Erythrocyte | 1 | 2015 | 8 | 0.130 |
Why?
| Antiporters | 1 | 2015 | 19 | 0.130 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 53 | 0.130 |
Why?
| S100 Proteins | 1 | 2015 | 34 | 0.130 |
Why?
| Breast | 1 | 2016 | 86 | 0.130 |
Why?
| Fibroma | 1 | 2015 | 39 | 0.120 |
Why?
| Lymphoma | 1 | 1996 | 65 | 0.120 |
Why?
| Arachidonic Acid | 4 | 1999 | 34 | 0.120 |
Why?
| Virus Replication | 3 | 2020 | 138 | 0.120 |
Why?
| Endosonography | 1 | 2015 | 94 | 0.120 |
Why?
| Calreticulin | 2 | 2004 | 10 | 0.120 |
Why?
| Heart Failure | 2 | 1999 | 505 | 0.110 |
Why?
| Aged, 80 and over | 3 | 2016 | 3138 | 0.110 |
Why?
| Multivariate Analysis | 1 | 2015 | 579 | 0.110 |
Why?
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2014 | 49 | 0.110 |
Why?
| Cholesterol | 1 | 2014 | 148 | 0.110 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 19 | 0.110 |
Why?
| Guanine Nucleotides | 1 | 1992 | 1 | 0.110 |
Why?
| Adult | 6 | 2020 | 13356 | 0.110 |
Why?
| Magnesium | 1 | 1992 | 36 | 0.100 |
Why?
| Transfection | 3 | 2009 | 354 | 0.100 |
Why?
| Structure-Activity Relationship | 2 | 2009 | 394 | 0.100 |
Why?
| Young Adult | 3 | 2020 | 4031 | 0.100 |
Why?
| Aged | 5 | 2020 | 9449 | 0.100 |
Why?
| Paraproteinemias | 1 | 2012 | 71 | 0.100 |
Why?
| Receptors, Histamine | 2 | 2023 | 7 | 0.100 |
Why?
| Receptors, Purinergic P2Y2 | 3 | 2001 | 11 | 0.100 |
Why?
| Gene Expression Regulation | 2 | 2019 | 964 | 0.100 |
Why?
| Blotting, Western | 2 | 2003 | 587 | 0.100 |
Why?
| Blood Platelets | 1 | 2014 | 249 | 0.100 |
Why?
| Uridine Triphosphate | 4 | 1999 | 15 | 0.090 |
Why?
| Kidney | 5 | 1999 | 672 | 0.090 |
Why?
| Immunologic Factors | 1 | 2011 | 112 | 0.090 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2021 | 212 | 0.090 |
Why?
| Disease Models, Animal | 3 | 2022 | 1411 | 0.090 |
Why?
| Liver | 2 | 1993 | 1106 | 0.090 |
Why?
| Receptors, Purinergic P2Y1 | 2 | 2001 | 7 | 0.090 |
Why?
| Risk Factors | 2 | 2015 | 3605 | 0.090 |
Why?
| Models, Biological | 3 | 2007 | 719 | 0.090 |
Why?
| Amino Acid Motifs | 1 | 2009 | 57 | 0.090 |
Why?
| Protein Structure, Tertiary | 3 | 2006 | 249 | 0.080 |
Why?
| Scavenger Receptors, Class B | 2 | 2006 | 10 | 0.080 |
Why?
| Protein Biosynthesis | 1 | 2011 | 252 | 0.080 |
Why?
| Tumor Cells, Cultured | 3 | 2020 | 462 | 0.080 |
Why?
| RNA, Messenger | 2 | 2011 | 1099 | 0.080 |
Why?
| Phosphorylation | 2 | 2006 | 526 | 0.080 |
Why?
| Time Factors | 3 | 2015 | 2891 | 0.080 |
Why?
| Treatment Outcome | 2 | 2015 | 5178 | 0.080 |
Why?
| Endothelial Cells | 2 | 2020 | 256 | 0.080 |
Why?
| Gene Expression Profiling | 2 | 2025 | 1028 | 0.080 |
Why?
| Group VI Phospholipases A2 | 1 | 2007 | 5 | 0.070 |
Why?
| Indomethacin | 2 | 1998 | 38 | 0.070 |
Why?
| Cyclooxygenase Inhibitors | 2 | 1998 | 37 | 0.070 |
Why?
| Serum Albumin, Bovine | 1 | 2006 | 22 | 0.070 |
Why?
| Cell Shape | 1 | 2006 | 20 | 0.070 |
Why?
| Rats | 4 | 2023 | 3273 | 0.070 |
Why?
| Malondialdehyde | 1 | 2006 | 50 | 0.070 |
Why?
| DNA, Complementary | 2 | 2004 | 134 | 0.070 |
Why?
| Severity of Illness Index | 2 | 2025 | 953 | 0.070 |
Why?
| Subcellular Fractions | 1 | 2006 | 34 | 0.070 |
Why?
| Femur | 1 | 2006 | 130 | 0.070 |
Why?
| Lung | 2 | 2020 | 501 | 0.070 |
Why?
| Disease Progression | 2 | 2021 | 820 | 0.060 |
Why?
| Chi-Square Distribution | 2 | 2016 | 275 | 0.060 |
Why?
| Terminology as Topic | 2 | 2017 | 63 | 0.060 |
Why?
| Lipid Metabolism | 1 | 2006 | 175 | 0.060 |
Why?
| Phosphoproteins | 1 | 2005 | 111 | 0.060 |
Why?
| Hepatocytes | 1 | 2006 | 179 | 0.060 |
Why?
| Muscle, Smooth, Vascular | 1 | 2005 | 131 | 0.060 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2005 | 129 | 0.060 |
Why?
| Cell Adhesion Molecules | 1 | 2004 | 87 | 0.060 |
Why?
| Receptors, Lipoprotein | 1 | 2003 | 7 | 0.060 |
Why?
| Antigen-Presenting Cells | 1 | 2003 | 24 | 0.060 |
Why?
| Cell Differentiation | 1 | 2006 | 649 | 0.060 |
Why?
| Peptides | 2 | 2004 | 220 | 0.060 |
Why?
| Gene Expression | 2 | 2025 | 612 | 0.060 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2003 | 2 | 0.060 |
Why?
| Amidohydrolases | 1 | 2003 | 5 | 0.060 |
Why?
| Tunicamycin | 1 | 2003 | 11 | 0.060 |
Why?
| Cations | 1 | 2003 | 10 | 0.060 |
Why?
| Brefeldin A | 1 | 2003 | 18 | 0.060 |
Why?
| Osteoclasts | 1 | 2006 | 424 | 0.060 |
Why?
| Biotinylation | 1 | 2003 | 26 | 0.060 |
Why?
| Glycoside Hydrolases | 1 | 2003 | 21 | 0.060 |
Why?
| Tetracycline | 1 | 2003 | 20 | 0.050 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2023 | 17 | 0.050 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 102 | 0.050 |
Why?
| Inflammation | 1 | 2007 | 603 | 0.050 |
Why?
| Research | 1 | 2023 | 107 | 0.050 |
Why?
| Receptors, Glucagon | 2 | 1993 | 9 | 0.050 |
Why?
| Chondroitin Sulfate Proteoglycans | 1 | 2023 | 18 | 0.050 |
Why?
| Receptors, Interleukin-1 | 1 | 2022 | 17 | 0.050 |
Why?
| Vesiculovirus | 1 | 2022 | 6 | 0.050 |
Why?
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2023 | 24 | 0.050 |
Why?
| Biopolymers | 1 | 2002 | 14 | 0.050 |
Why?
| Muscle Proteins | 1 | 2005 | 316 | 0.050 |
Why?
| Antigens, Neoplasm | 1 | 2003 | 146 | 0.050 |
Why?
| Genetic Vectors | 1 | 2003 | 128 | 0.050 |
Why?
| Rabbits | 2 | 2000 | 375 | 0.050 |
Why?
| Prostate-Specific Antigen | 1 | 2023 | 47 | 0.050 |
Why?
| Medical Oncology | 1 | 2023 | 95 | 0.050 |
Why?
| Adaptive Immunity | 1 | 2022 | 31 | 0.050 |
Why?
| Microscopy, Fluorescence | 1 | 2003 | 164 | 0.050 |
Why?
| Endoplasmic Reticulum | 1 | 2003 | 118 | 0.050 |
Why?
| Phospholipases A | 2 | 1999 | 14 | 0.050 |
Why?
| Actins | 1 | 2002 | 115 | 0.050 |
Why?
| Isoproterenol | 3 | 1999 | 56 | 0.050 |
Why?
| Prostate | 1 | 2023 | 117 | 0.050 |
Why?
| Adenosine Monophosphate | 1 | 2022 | 15 | 0.050 |
Why?
| Alanine | 1 | 2022 | 41 | 0.050 |
Why?
| Cell Cycle | 1 | 2023 | 226 | 0.050 |
Why?
| Program Evaluation | 1 | 2023 | 349 | 0.050 |
Why?
| Endocytosis | 2 | 2017 | 61 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 579 | 0.050 |
Why?
| Herpesvirus 4, Human | 1 | 2022 | 39 | 0.050 |
Why?
| Golgi Apparatus | 1 | 2003 | 114 | 0.050 |
Why?
| RNA, Viral | 1 | 2022 | 124 | 0.050 |
Why?
| Protein Kinase C | 2 | 2005 | 70 | 0.050 |
Why?
| Benzamidines | 1 | 2021 | 5 | 0.050 |
Why?
| Azithromycin | 1 | 2021 | 25 | 0.050 |
Why?
| Kidney Tubules, Collecting | 1 | 2001 | 9 | 0.050 |
Why?
| Guanidines | 1 | 2021 | 29 | 0.050 |
Why?
| Kidney Tubules, Distal | 1 | 2001 | 14 | 0.050 |
Why?
| Nucleotides | 1 | 2001 | 24 | 0.050 |
Why?
| Amino Acids | 1 | 2003 | 363 | 0.050 |
Why?
| Wasp Venoms | 1 | 2000 | 1 | 0.050 |
Why?
| Cholesterol Esters | 1 | 2000 | 4 | 0.050 |
Why?
| Promoter Regions, Genetic | 1 | 2003 | 467 | 0.050 |
Why?
| Androstadienes | 1 | 2000 | 10 | 0.050 |
Why?
| Iodine Radioisotopes | 1 | 2000 | 36 | 0.050 |
Why?
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2000 | 3 | 0.050 |
Why?
| Mice, Inbred NOD | 1 | 2020 | 94 | 0.050 |
Why?
| Curriculum | 1 | 2023 | 397 | 0.040 |
Why?
| Bacteroidaceae Infections | 1 | 2020 | 4 | 0.040 |
Why?
| Mice, Inbred Strains | 1 | 2000 | 160 | 0.040 |
Why?
| Biological Transport, Active | 1 | 2000 | 32 | 0.040 |
Why?
| Mice, SCID | 1 | 2020 | 173 | 0.040 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2000 | 100 | 0.040 |
Why?
| Gene Expression Regulation, Viral | 1 | 2020 | 48 | 0.040 |
Why?
| Rats, Sprague-Dawley | 3 | 2005 | 1578 | 0.040 |
Why?
| Acetylation | 1 | 2000 | 92 | 0.040 |
Why?
| Dinoprostone | 2 | 1999 | 48 | 0.040 |
Why?
| Tissue Array Analysis | 1 | 2019 | 45 | 0.040 |
Why?
| High-Throughput Screening Assays | 1 | 2019 | 35 | 0.040 |
Why?
| Viral Proteins | 1 | 2021 | 156 | 0.040 |
Why?
| Paraffin Embedding | 1 | 2019 | 52 | 0.040 |
Why?
| HIV | 1 | 2019 | 25 | 0.040 |
Why?
| Tumor Escape | 1 | 2019 | 16 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2020 | 167 | 0.040 |
Why?
| Virulence Factors | 1 | 2020 | 78 | 0.040 |
Why?
| Drosophila melanogaster | 1 | 2019 | 31 | 0.040 |
Why?
| Glycosylation | 1 | 2019 | 102 | 0.040 |
Why?
| Drug Evaluation, Preclinical | 1 | 2019 | 145 | 0.040 |
Why?
| Calcium-Transporting ATPases | 1 | 1999 | 14 | 0.040 |
Why?
| Sarcoplasmic Reticulum | 1 | 1999 | 21 | 0.040 |
Why?
| Gene Knockdown Techniques | 1 | 2019 | 106 | 0.040 |
Why?
| Cholera Toxin | 2 | 1995 | 15 | 0.040 |
Why?
| Calcium-Binding Proteins | 1 | 1999 | 54 | 0.040 |
Why?
| Antibodies, Monoclonal | 1 | 2023 | 457 | 0.040 |
Why?
| Interleukin-1beta | 1 | 2019 | 73 | 0.040 |
Why?
| Thionucleotides | 1 | 1998 | 10 | 0.040 |
Why?
| Autocrine Communication | 1 | 1998 | 8 | 0.040 |
Why?
| Suramin | 1 | 1998 | 13 | 0.040 |
Why?
| HEK293 Cells | 1 | 2019 | 216 | 0.040 |
Why?
| Prostaglandins | 1 | 1998 | 20 | 0.040 |
Why?
| Paracrine Communication | 1 | 1998 | 12 | 0.040 |
Why?
| Myocardial Contraction | 1 | 1999 | 110 | 0.040 |
Why?
| Neoplasm Metastasis | 1 | 2019 | 235 | 0.040 |
Why?
| Receptors, Adrenergic, alpha-1 | 1 | 1998 | 15 | 0.040 |
Why?
| Multiple Myeloma | 1 | 2012 | 2916 | 0.040 |
Why?
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 15 | 0.040 |
Why?
| Isoenzymes | 1 | 1998 | 168 | 0.040 |
Why?
| Pandemics | 1 | 2022 | 567 | 0.040 |
Why?
| Phagocytosis | 1 | 2017 | 49 | 0.040 |
Why?
| Staphylococcus aureus | 1 | 2020 | 327 | 0.030 |
Why?
| Vimentin | 1 | 2016 | 32 | 0.030 |
Why?
| Receptors, G-Protein-Coupled | 1 | 1996 | 53 | 0.030 |
Why?
| Purinergic P1 Receptor Agonists | 1 | 1996 | 2 | 0.030 |
Why?
| Phospholipases | 1 | 1996 | 2 | 0.030 |
Why?
| Purinergic P2 Receptor Agonists | 1 | 1996 | 4 | 0.030 |
Why?
| Radioligand Assay | 1 | 1996 | 46 | 0.030 |
Why?
| Algorithms | 1 | 2019 | 613 | 0.030 |
Why?
| Cadherins | 1 | 2016 | 64 | 0.030 |
Why?
| Cytochalasin B | 1 | 1995 | 2 | 0.030 |
Why?
| beta Catenin | 1 | 2016 | 101 | 0.030 |
Why?
| Cerebral Cortex | 1 | 1996 | 195 | 0.030 |
Why?
| Colchicine | 1 | 1995 | 24 | 0.030 |
Why?
| Cohort Studies | 1 | 2019 | 1403 | 0.030 |
Why?
| Apoptosis | 1 | 2020 | 1092 | 0.030 |
Why?
| Neoplasm Grading | 1 | 2015 | 123 | 0.030 |
Why?
| Biopsy, Fine-Needle | 1 | 2015 | 108 | 0.030 |
Why?
| Lymphatic Metastasis | 1 | 2015 | 226 | 0.030 |
Why?
| Neoplasm, Residual | 1 | 2015 | 157 | 0.030 |
Why?
| Macrophage-1 Antigen | 1 | 2014 | 6 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2014 | 37 | 0.030 |
Why?
| Ligation | 1 | 2014 | 61 | 0.030 |
Why?
| Interleukin-4 | 1 | 2014 | 44 | 0.030 |
Why?
| Cecum | 1 | 2014 | 59 | 0.030 |
Why?
| Cell Communication | 1 | 2014 | 69 | 0.030 |
Why?
| Hemostasis | 1 | 2014 | 56 | 0.030 |
Why?
| Heart Ventricles | 1 | 1995 | 252 | 0.030 |
Why?
| Neurons | 1 | 1996 | 455 | 0.030 |
Why?
| Guanosine Diphosphate | 1 | 1992 | 8 | 0.030 |
Why?
| Saponins | 1 | 1992 | 6 | 0.030 |
Why?
| Guanosine Triphosphate | 1 | 1992 | 20 | 0.030 |
Why?
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1992 | 15 | 0.030 |
Why?
| Binding, Competitive | 1 | 1993 | 94 | 0.030 |
Why?
| Cell Membrane Permeability | 1 | 1992 | 28 | 0.030 |
Why?
| Fibrinogen | 1 | 2012 | 32 | 0.030 |
Why?
| Neutrophils | 1 | 2014 | 148 | 0.030 |
Why?
| Reference Values | 1 | 2012 | 302 | 0.030 |
Why?
| Receptors, Neurotransmitter | 1 | 1992 | 16 | 0.030 |
Why?
| Receptors, Somatostatin | 1 | 1992 | 3 | 0.030 |
Why?
| Temperature | 1 | 1992 | 163 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 388 | 0.020 |
Why?
| Kinetics | 1 | 1992 | 632 | 0.020 |
Why?
| Thrombosis | 1 | 2014 | 249 | 0.020 |
Why?
| Prognosis | 1 | 2015 | 1957 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2015 | 2177 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 2 | 2004 | 1354 | 0.020 |
Why?
| Lipoproteins, HDL | 1 | 2006 | 18 | 0.020 |
Why?
| United States | 1 | 2017 | 4883 | 0.020 |
Why?
| Tissue Distribution | 1 | 2006 | 163 | 0.020 |
Why?
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2005 | 7 | 0.020 |
Why?
| Myosin-Light-Chain Phosphatase | 1 | 2005 | 3 | 0.020 |
Why?
| rhoA GTP-Binding Protein | 1 | 2005 | 7 | 0.020 |
Why?
| Maleimides | 1 | 2005 | 8 | 0.020 |
Why?
| rho-Associated Kinases | 1 | 2005 | 20 | 0.020 |
Why?
| Amides | 1 | 2005 | 36 | 0.020 |
Why?
| Immunoblotting | 1 | 2005 | 116 | 0.020 |
Why?
| Mesenteric Arteries | 1 | 2005 | 46 | 0.020 |
Why?
| RANK Ligand | 1 | 2006 | 179 | 0.020 |
Why?
| Sex Characteristics | 1 | 2006 | 191 | 0.020 |
Why?
| Muscle Contraction | 1 | 2005 | 111 | 0.020 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 139 | 0.020 |
Why?
| Scavenger Receptors, Class F | 1 | 2004 | 2 | 0.020 |
Why?
| Aorta | 1 | 2005 | 162 | 0.010 |
Why?
| Body Weight | 1 | 2006 | 512 | 0.010 |
Why?
| Pyridines | 1 | 2005 | 133 | 0.010 |
Why?
| Bone Density | 1 | 2006 | 383 | 0.010 |
Why?
| CHO Cells | 1 | 2004 | 121 | 0.010 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2004 | 62 | 0.010 |
Why?
| Cricetinae | 1 | 2004 | 211 | 0.010 |
Why?
| Polysaccharides | 1 | 2004 | 51 | 0.010 |
Why?
| Molecular Chaperones | 1 | 2004 | 63 | 0.010 |
Why?
| Fluorescent Dyes | 1 | 2004 | 105 | 0.010 |
Why?
| Polymerase Chain Reaction | 2 | 1998 | 456 | 0.010 |
Why?
| Insulin | 1 | 2006 | 453 | 0.010 |
Why?
| Bone Marrow Cells | 1 | 2004 | 190 | 0.010 |
Why?
| Dendritic Cells | 1 | 2004 | 133 | 0.010 |
Why?
| Body Mass Index | 1 | 2006 | 648 | 0.010 |
Why?
| Glucose | 1 | 2005 | 337 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 378 | 0.010 |
Why?
| Base Sequence | 2 | 1996 | 657 | 0.010 |
Why?
| Indoles | 1 | 2005 | 273 | 0.010 |
Why?
| Phospholipase D | 1 | 1999 | 7 | 0.010 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 36 | 0.010 |
Why?
| Papillary Muscles | 1 | 1999 | 17 | 0.010 |
Why?
| Transduction, Genetic | 1 | 1999 | 45 | 0.010 |
Why?
| Feedback | 1 | 1999 | 52 | 0.010 |
Why?
| Epinephrine | 1 | 1999 | 97 | 0.010 |
Why?
| Diglycerides | 1 | 1998 | 9 | 0.010 |
Why?
| Phosphatidylinositols | 1 | 1998 | 27 | 0.010 |
Why?
| Arachidonic Acids | 1 | 1998 | 22 | 0.010 |
Why?
| Potassium Channels | 1 | 1998 | 33 | 0.010 |
Why?
| Inositol 1,4,5-Trisphosphate | 1 | 1996 | 10 | 0.010 |
Why?
| Receptors, Lysophosphatidic Acid | 1 | 1996 | 5 | 0.010 |
Why?
| Phosphatidylcholines | 1 | 1996 | 24 | 0.010 |
Why?
| Cell Size | 1 | 1996 | 46 | 0.010 |
Why?
| Embryo, Mammalian | 1 | 1996 | 67 | 0.010 |
Why?
| Animals, Newborn | 1 | 1998 | 367 | 0.010 |
Why?
| Lysophospholipids | 1 | 1996 | 44 | 0.010 |
Why?
| Gene Expression Regulation, Developmental | 1 | 1996 | 137 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1996 | 296 | 0.010 |
Why?
| Cytoskeleton | 1 | 1995 | 41 | 0.010 |
Why?
| Age Factors | 1 | 1996 | 1092 | 0.010 |
Why?
| Digestive System Physiological Phenomena | 1 | 1992 | 3 | 0.010 |
Why?
| Genes | 1 | 1992 | 34 | 0.010 |
Why?
| Blotting, Southern | 1 | 1992 | 43 | 0.010 |
Why?
| Islets of Langerhans | 1 | 1992 | 25 | 0.010 |
Why?
| Blotting, Northern | 1 | 1992 | 110 | 0.010 |
Why?
| Somatostatin | 1 | 1992 | 31 | 0.010 |
Why?
| Sequence Alignment | 1 | 1992 | 121 | 0.010 |
Why?
| Cloning, Molecular | 1 | 1992 | 189 | 0.010 |
Why?
| Pregnancy | 1 | 1996 | 2468 | 0.010 |
Why?
| DNA | 1 | 1992 | 543 | 0.000 |
Why?
| Brain | 1 | 1992 | 1310 | 0.000 |
Why?
|
|
Post's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|